Prevalence of psychological distress, quality of life, and satisfaction among patients and family members following comprehensive genomic profiling testing: Protocol of the Quality of life for Cancer genomics and Advanced Therapeutics (Q-CAT) study

Precision medicine is rapidly changing the diagnostic and treatment spectrum of oncology. In May 2019, comprehensive genomic profiling (CGP) (somatic and/or germline) was approved for reimbursement in Japan. While the promise of novel and targeted therapies has elevated hopes for the benefits of CGP...

Descripción completa

Detalles Bibliográficos
Autores principales: Nishino, Makoto, Fujimori, Maiko, Koyama, Takafumi, Hirata, Makoto, Tanabe, Noriko, Shimizu, Toshio, Yamamoto, Noboru, Uchitomi, Yosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218744/
https://www.ncbi.nlm.nih.gov/pubmed/37235572
http://dx.doi.org/10.1371/journal.pone.0283968

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218744/
https://www.ncbi.nlm.nih.gov/pubmed/37235572
http://dx.doi.org/10.1371/journal.pone.0283968

Ejemplares similares